[
  {
    "date": "2023-12-30",
    "symbol": "KPRX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36672",
    "entityregistrantname": "KIORA PHARMACEUTICALS, INC",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "98-0443284",
    "entityaddressaddressline1": "332 Encinitas Blvd.",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Encinitas",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92024,
    "cityareacode": 858,
    "localphonenumber": "224-9600",
    "security12btitle": "Common Stock, $0.01 par value",
    "tradingsymbol": "KPRX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1372514,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 200,
    "auditorname": "HASKELL & WHITE LLP",
    "auditorlocation": "Irvine, California",
    "cashandcashequivalentsatcarryingvalue": 2454684,
    "prepaidexpenseandotherassetscurrent": 233382,
    "incometaxesreceivable": 2049965,
    "assetscurrent": 4738031,
    "propertyplantandequipmentnet": 8065,
    "restrictedcashandcashequivalentsnoncurrent": 4267,
    "intangibleassetsnetexcludinggoodwill": 8813850,
    "operatingleaserightofuseasset": 106890,
    "otherassetsnoncurrent": 40767,
    "assets": 13711870,
    "accountspayablecurrent": 206260,
    "accruedliabilitiescurrent": 1380666,
    "operatingleaseliabilitycurrent": 47069,
    "businesscombinationcontingentconsiderationliabilitycurrent": 1000000,
    "liabilitiescurrent": 1633995,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 5128959,
    "deferredincometaxliabilitiesnet": 779440,
    "operatingleaseliabilitynoncurrent": 59822,
    "liabilitiesnoncurrent": 5968221,
    "liabilities": 7602216,
    "preferredstockvalue": 4,
    "commonstockvalue": 77078,
    "additionalpaidincapital": 153192228,
    "retainedearningsaccumulateddeficit": -146976855,
    "accumulatedothercomprehensiveincomelossnetoftax": -182801,
    "stockholdersequity": 6109654,
    "liabilitiesandstockholdersequity": 13711870,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockdesignatedshares": 3750,
    "preferredstocksharesissued": 7,
    "preferredstocksharesoutstanding": 7,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 7705640,
    "commonstocksharesoutstanding": 7705640,
    "generalandadministrativeexpense": 4663146,
    "researchanddevelopmentexpense": 4027037,
    "impairmentofintangibleassetsindefinitelivedexcludinggoodwill": 1904314,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 1992399,
    "operatingexpenses": 12586896,
    "operatingincomeloss": -12586896,
    "gainlossonsaleofpropertyplantequipment": -28379,
    "investmentincomeinterest": 173989,
    "interestexpense": 11132,
    "othernonoperatingincomeexpense": 28841,
    "nonoperatingincomeexpense": 163319,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -12423577,
    "incometaxexpensebenefit": 90319,
    "netincomeloss": -12513896,
    "warrantdownroundfeaturedecreaseinnetincomelosstocommonshareholderamount": 530985,
    "netincomelossfromdiscontinuedoperationsavailabletocommonshareholdersbasic": -13044881,
    "netincomelossfromdiscontinuedoperationsavailabletocommonshareholdersdiluted": -13044881,
    "earningspersharebasic": -2.69,
    "earningspersharediluted": -2.69,
    "weightedaveragenumberofsharesoutstandingbasic": 4842067,
    "weightedaveragenumberofdilutedsharesoutstanding": 4842067,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -60,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -12513956,
    "sharesoutstanding": 427,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 754944,
    "stockissuedduringperiodsharesnewissues": 2197628,
    "stockissuedduringperiodvaluenewissues": 21976,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 2931218,
    "stockissuedduringperiodshareswarrantsexercised": 66400,
    "stockissuedduringperiodvaluewarrantsexercised": 664,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -3488,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -35,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 296750,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 2968,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletononcontrollinginterest": 60,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 132684,
    "adjustmenttoadditionalpaidincapitalwarrantissuancecosts": 381877,
    "gainorlossonsaleofstockinsubsidiary": 53882,
    "depreciationdepletionandamortization": 51798,
    "increasedecreaseinrightofuseassets": 10626,
    "sharebasedcompensation": 754944,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliabilities": 1992399,
    "deferredincometaxesandtaxcredits": 90319,
    "gainlossondispositionofassets1": -28379,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -885,
    "increasedecreaseinincometaxesreceivable": 548109,
    "increasedecreaseinotheroperatingassets": 7583,
    "increasedecreaseinaccountspayable": -808016,
    "increasedecreaseinoperatingleaseliability": 584,
    "increasedecreaseinaccruedliabilities": -459713,
    "netcashprovidedbyusedinoperatingactivities": -9556951,
    "proceedsfromissuanceofcommonstock": 5595962,
    "proceedsfromwarrantexercises": 307079,
    "proceedsfromissuanceofprivateplacement": 115715,
    "paymentforcontingentconsiderationliabilityfinancingactivities": 495000,
    "netcashprovidedbyusedinfinancingactivities": 5966066,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 36020,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -3554865,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2458951,
    "conversionofstockamountconverted1": 31706,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 114747,
    "grantofrestrictedstockawards": 10345,
    "warrantsdisclosuretextblock": "Warrants",
    "researchanddevelopmentrefundspolicypolicytextblock": "Refunds for Research and Development",
    "employeeandnonemployeeservicesharebasedcompensationallocationofrecognizedperiodcoststabletextblock": "The total stock-based compensation expense for employees and non-employees is included in the accompanying Consolidated Statements of Operations and as follows:Year Ended December 31,20232022General and Administrative$345,488 $343,475 Research and Development409,456 118,975 Total Stock-Based Compensation Expense$754,944 $462,450",
    "numberofanteriorsegmentassets": 2,
    "substantialdoubtaboutgoingconcernmanagementsevaluationforwardlookingperiod": "P24M",
    "propertyplantandequipmentusefullife": "P2Y",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles": 8700000,
    "numberofoperatingsegments": 1,
    "numberofgeographicsegments": 3,
    "deferredtaxliabilities": 800000,
    "incometaxreceivable": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 229373,
    "relatedpartytransactionsnumberofvendors": 1,
    "relatedpartytransactionsnumberofemployees": 3,
    "relatedpartytransactionsnumberofconsultants": 15,
    "relatedpartytransactionamountsoftransaction": 100000,
    "relatedpartytransactionnumberofdirectors": 1,
    "finitelivedintangibleassetsfairvaluedisclosure": 8700000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13064299,
    "businesscombinationcontingentconsiderationliability": 5128959,
    "changeincontingentconsiderationfairvalue": 1500000,
    "businesscombinationcontingentconsiderationliabilitymeasurementinput": 0.131,
    "propertyplantandequipmentgross": 11832,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6289,
    "depreciation": 30000,
    "employeerelatedliabilitiescurrent": 875254,
    "accruedprofessionalfeescurrent": 43387,
    "clinicaltrialscurrent": 397465,
    "otheraccruedliabilitiescurrent": 64560,
    "amortizationofintangibleassets": 25000,
    "finitelivedintangibleassetusefullife": "P10Y",
    "finitelivedintangibleassetsgross": 250000,
    "finitelivedintangibleassetsaccumulatedamortization": 131250,
    "finitelivedintangibleassetsnet": 118750,
    "finitelivedintangibleassetsresearchanddevelopment": 8695100,
    "intangibleassetsnetincludinginprocessresearchanddevelopment": 8813850,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 25000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 18750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 11605596,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 66400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 72503,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedweightedaverageexerciseprice": 0.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 5.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexpiredweightedaverageexerciseprice": 108.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y5M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageremainingcontractualterms": "P3Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1298848,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 183604,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 764400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodfairvalues": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "shareprice": 0.522,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 812945,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 927,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 35279,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 173394,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 812945,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 373.32,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 4.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P9Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0395,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0461,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.452,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 3.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 345488,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -9384178,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -3039399,
    "deferredfederalincometaxexpensebenefit": -280954,
    "deferredstateandlocalincometaxexpensebenefit": 371273,
    "deferredfederalstateandlocaltaxexpensebenefit": 90319,
    "deferredincometaxexpensebenefit": 90319,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.1326,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": -0.0349,
    "effectiveincometaxratereconciliationtaxcontingencies": -0.0336,
    "effectiveincometaxratereconciliationgiltipercent": -0.0112,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0065,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2761,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.0024,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0032,
    "effectiveincometaxratereconciliationtaxcreditsother": 0.0008,
    "effectiveincometaxratereconciliationotheradjustments": 0.0076,
    "effectiveincometaxratecontinuingoperations": -0.0073,
    "deferredtaxassetsoperatinglosscarryforwards": 25982646,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2955627,
    "deferredtaxassetsinprocessresearchanddevelopment": 4743068,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 784366,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 77729,
    "deferredtaxassetsgross": 34543436,
    "deferredtaxassetsvaluationallowance": 33025829,
    "deferredtaxassetsnet": 1517607,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 2297047,
    "operatinglosscarryforwards": 90200000,
    "taxcreditcarryforwardamount": 2500000,
    "valuationallowancedeferredtaxassetchangeinamount": 3400000,
    "lesseenumberofoperatingleases": 3,
    "ceasepaymentsnotyetpaidbasedonprevailingfinancialmarketconditions": 0.085,
    "operatingleaserightofuseassetamortizationexpense": 200000,
    "numberoflicenseagreements": 7,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 53966,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 27566,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 14366,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 14372,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfive": 11373,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 14755,
    "operatingleaseliability": 106890
  },
  {
    "date": "2022-12-30",
    "symbol": "KPRX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36672",
    "entityregistrantname": "KIORA PHARMACEUTICALS, INC",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "98-0443284",
    "entityaddressaddressline1": "332 Encinitas Blvd.",
    "entityaddressaddressline2": "Suite 102",
    "entityaddresscityortown": "Encinitas",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92024,
    "cityareacode": 781,
    "localphonenumber": "788-8869",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "tradingsymbol": "KPRX",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1372514,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorfirmid": 274,
    "auditorname": "EISNERAMPER LLP",
    "auditorlocation": "Iselin, New Jersey",
    "cashandcashequivalentsatcarryingvalue": 5964556,
    "prepaidexpenseandotherassetscurrent": 343069,
    "incometaxesreceivable": 1373041,
    "assetscurrent": 7680666,
    "propertyplantandequipmentnet": 55177,
    "restrictedcashandcashequivalentsnoncurrent": 49260,
    "intangibleassetsnetexcludinggoodwill": 10743164,
    "operatingleaserightofuseasset": 116992,
    "otherassetsnoncurrent": 33000,
    "assets": 18678259,
    "accountspayablecurrent": 1008262,
    "accruedliabilitiescurrent": 1835934,
    "operatingleaseliabilitycurrent": 105782,
    "businesscombinationcontingentconsiderationliabilitycurrent": 322385,
    "liabilitiescurrent": 3272363,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 3309175,
    "deferredincometaxliabilitiesnet": 689121,
    "liabilitiesnoncurrent": 3998296,
    "liabilities": 7270659,
    "commonstockvalue": 17986,
    "additionalpaidincapital": 146035314,
    "retainedearningsaccumulateddeficit": -134462959,
    "accumulatedothercomprehensiveincomelossnetoftax": -182741,
    "stockholdersequity": 11407600,
    "liabilitiesandstockholdersequity": 18678259,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockdesignatedshares": 3750,
    "preferredstocksharesissued": 7,
    "preferredstocksharesoutstanding": 7,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 50000000,
    "commonstocksharesissued": 1796472,
    "commonstocksharesoutstanding": 1796472,
    "researchanddevelopmentexpense": 3448925,
    "generalandadministrativeexpense": 8277993,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 582605,
    "operatingexpenses": 12309523,
    "operatingincomeloss": -12309523,
    "fairvalueadjustmentofwarrants": 1425102,
    "gainlossondispositionofassets1": 4211,
    "investmentincomeinterest": 56891,
    "interestexpense": 8599,
    "foreigncurrencytransactiongainlossbeforetax": -14498,
    "nonoperatingincomeexpense": -1387097,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -13696620,
    "incometaxexpensebenefit": -113010,
    "netincomeloss": -13583610,
    "earningspersharebasic": -18.55,
    "earningspersharediluted": -18.55,
    "weightedaveragenumberofsharesoutstandingbasic": 732303,
    "weightedaveragenumberofdilutedsharesoutstanding": 732303,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -96310,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -13679920,
    "sharesoutstanding": 7,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 462450,
    "stockissuedduringperiodsharesfromholdbackshares": 10087,
    "stockissuedduringperiodvaluefrompanoptesholdbackshares": 100,
    "stockissuedduringperiodsharesnewissues": 592392,
    "stockissuedduringperiodvaluenewissues": 5924,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -1280,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -13,
    "adjustmentstoadditionalpaidincapitalreclassificationofwarrantliability": 3674791,
    "stockadjustmentduringperiodsharesreversestocksplits": 2215,
    "stockadjustedduringperiodvaluereversestocksplits": 15629,
    "stockissuedduringperiodshareswarrantsexercised": 65000,
    "stockissuedduringperiodvaluewarrantsexercised": 650,
    "stockissuedduringperiodshareswarrantinducement": 654609,
    "stockissuedduringperiodvaluewarrantinducement": 6546,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletononcontrollinginterest": 96310,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 505020,
    "adjustmenttoadditionalpaidincapitalwarrantissuancecosts": 381360,
    "depreciationdepletionandamortization": 41609,
    "increasedecreaseinrightofuseassets": 92419,
    "sharebasedcompensation": 462450,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliabilities": 582605,
    "deferredincometaxesandtaxcredits": -113010,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -275161,
    "increasedecreaseinincometaxesreceivable": 872736,
    "increasedecreaseinotheroperatingassets": 22465,
    "increasedecreaseinaccountspayable": 782463,
    "increasedecreaseinoperatingleaseliability": -103629,
    "increasedecreaseinaccruedliabilities": 609719,
    "netcashprovidedbyusedinoperatingactivities": -10428133,
    "proceedsfromsaleofpropertyplantandequipment": 6375,
    "netcashprovidedbyusedininvestingactivities": 6375,
    "proceedsfromissuanceofcommonstock": 5377719,
    "proceedsfromissuanceofwarrants": 2738831,
    "proceedsfromwarrantexercises": 520000,
    "paymentsforfractionalsharesrelatedtoreversestocksplit": 15629,
    "netcashprovidedbyusedinfinancingactivities": 8620921,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -85037,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1885874,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 6013816,
    "conversionofstockamountconverted1": 1600,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 55415,
    "grantofrestrictedstockawards": 300,
    "propertyplantandequipmentusefullife": "P2Y",
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles": 10600000,
    "numberofoperatingsegments": 1,
    "numberofgeographicsegments": 3,
    "deferredtaxliabilities": 700000,
    "incometaxreceivable": 1300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 30000,
    "relatedpartytransactionsnumberofvendors": 1,
    "relatedpartytransactionsnumberofconsultants": 6,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 100000,
    "numberofboardofdirectorswhoarealsoexecutivesatarelatedparty": 1,
    "duetorelatedpartiescurrent": 100000,
    "businesscombinationcontingentconsiderationliability": 1100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1597606,
    "businesscombinationcontingentconsiderationliabilitymeasurementinput": 0.147,
    "changeincontingentconsiderationfairvalue": 600000,
    "propertyplantandequipmentgross": 88399,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 117319,
    "depreciation": 16596,
    "employeerelatedliabilitiescurrent": 1312443,
    "accruedprofessionalfeescurrent": 282721,
    "clinicaltrialscurrent": 57020,
    "otheraccruedliabilitiescurrent": 183750,
    "amortizationofintangibleassets": 25000,
    "finitelivedintangibleassetusefullife": "P10Y",
    "finitelivedintangibleassetsgross": 250000,
    "finitelivedintangibleassetsaccumulatedamortization": 106250,
    "finitelivedintangibleassetsnet": 143750,
    "finitelivedintangibleassetsresearchanddevelopment": 10599414,
    "intangibleassetsnetincludinginprocessresearchanddevelopment": 10743164,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 25000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 25000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 25000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 18750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2159395,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 719609,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 11112,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 21.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedweightedaverageexerciseprice": 7.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 5.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexpiredweightedaverageexerciseprice": 900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P3Y25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageremainingcontractualterms": "P2Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 84751,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 78641,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 6830,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4939,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 84751,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 36.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.49,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 842.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 446.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 442.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 36.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y3M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P9Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 220733,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 27.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodfairvalues": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 101850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0242,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 261.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 261.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 343475,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -10563302,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -3133318,
    "deferredfederalincometaxexpensebenefit": 4954,
    "deferredstateandlocalincometaxexpensebenefit": -117964,
    "deferredfederalstateandlocaltaxexpensebenefit": -113010,
    "deferredincometaxexpensebenefit": -113010,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.0259,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0924,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.0953,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0058,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0289,
    "effectiveincometaxratereconciliationotheradjustments": -0.0026,
    "effectiveincometaxratecontinuingoperations": 0.0284,
    "deferredtaxassetsoperatinglosscarryforwards": 22809667,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2925890,
    "deferredtaxassetsinprocessresearchanddevelopment": 4606902,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 782355,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 336360,
    "deferredtaxassetsgross": 31461174,
    "deferredtaxassetsvaluationallowance": 29593286,
    "deferredtaxassetsnet": 1867888,
    "deferredtaxliabilitiespropertyplantandequipment": 477,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 2556532,
    "operatinglosscarryforwards": 80500000,
    "taxcreditcarryforwardamount": 2500000,
    "valuationallowancedeferredtaxassetchangeinamount": 1300000,
    "lesseenumberofoperatingleases": 3,
    "ceasepaymentsnotyetpaidbasedonprevailingfinancialmarketconditions": 0.1,
    "operatingleaserightofuseassetamortizationexpense": 100000,
    "numberoflicenseagreements": 7,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 105523,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1830,
    "operatingleaseliability": 103693,
    "definedbenefitplancontributionsbyemployeraccrued": 8500
  },
  {
    "date": "2019-12-30",
    "symbol": "KPRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "EYEGATE PHARMACEUTICALS INC",
    "entitycentralindexkey": 1372514,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entityshellcompany": "false",
    "tradingsymbol": "EYEG",
    "cashandcashequivalentsatcarryingvalue": 3776712,
    "prepaidexpenseandotherassetscurrent": 458810,
    "operatingleaserightofuseassetcurrent": 83926,
    "incometaxesreceivable": 4857,
    "assetscurrent": 4324305,
    "propertyplantandequipmentnet": 16846,
    "restrictedcashandcashequivalentsnoncurrent": 45000,
    "goodwill": 1525896,
    "intangibleassetsnetexcludinggoodwill": 15000,
    "otherassetsnoncurrent": 69403,
    "assets": 10112514,
    "accountspayablecurrent": 210289,
    "accruedliabilitiescurrent": 1120480,
    "operatingleaseliability": 83926,
    "liabilitiescurrent": 1414695,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 1710000,
    "deferredincometaxliabilitiesnet": 365364,
    "liabilitiesnoncurrent": 2075364,
    "liabilities": 3490059,
    "preferredstockvalue": 41,
    "commonstockvalue": 40778,
    "additionalpaidincapital": 106689065,
    "retainedearningsaccumulateddeficit": -100246894,
    "accumulatedothercomprehensiveincomelossnetoftax": 139465,
    "stockholdersequity": 41,
    "liabilitiesandstockholdersequity": 10112514,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 4077755,
    "commonstocksharesoutstanding": 4077755,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 9994184,
    "preferredstocksharesissued": 4092,
    "preferredstocksharesoutstanding": 4092,
    "preferredstockdesignatedshares": 10000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 2686000,
    "researchanddevelopmentexpense": 5389357,
    "generalandadministrativeexpense": 4405684,
    "operatingexpenses": 9795041,
    "investmentincomeinterest": 108066,
    "interestexpense": 325,
    "nonoperatingincomeexpense": 107741,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -7001300,
    "incometaxexpensebenefit": 95396,
    "netincomeloss": -7096696,
    "earningspersharebasicanddiluted": -2.23,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 3181019,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 5134,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -7091562,
    "sharesoutstanding": 4092,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 852230,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 97082,
    "stockissuedduringperiodvaluenewissues": 6000,
    "stockissuedduringperiodsharesnewissues": 600000,
    "stockissuedduringperiodsharescancellationoffractionalsharesduetoreversestocksplit": 23,
    "stockissuedduringperiodvaluesettlementoffractionalsharesduetoreversestocksplit": 9,
    "stockissuedduringperiodsharessettlementoffractionalsharesduetoreversestocksplit": 907,
    "stockissuedduringperiodsharesstockoptionsexercised": 447961,
    "stockissuedduringperiodvaluewarrantsexercised": 4480,
    "stockissuedduringperiodshareswarrantsexercised": 447961,
    "stockissuedduringperiodvaluerestrictedstockawardgross": -79,
    "stockissuedduringperiodsharesrestrictedstockawardgross": -7868,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletononcontrollinginterest": -5134,
    "depreciationdepletionandamortization": 51672,
    "increasedecreaseinrightofuseassets": 162261,
    "sharebasedcompensation": 852230,
    "contingentconsideration": 500000,
    "deferredincometaxesandtaxcredits": 95396,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3051,
    "increasedecreaseinincometaxesreceivable": -13210,
    "increasedecreaseinotheroperatingassets": 37697,
    "increasedecreaseinaccountspayable": 146636,
    "increasedecreaseinleaseliabilities": 162261,
    "increasedecreaseincontractwithcustomerliability": -2686000,
    "increasedecreaseinaccruedliabilities": 10467,
    "netcashprovidedbyusedinoperatingactivities": -8153833,
    "proceedsfromissuanceofcommonstock": 1777918,
    "proceedsfromwarrantexercises": 2150216,
    "paymentsforsettlementoffractionalshares": 2614,
    "paymentsoffinancingcosts": 4715,
    "netcashprovidedbyusedinfinancingactivities": 3920805,
    "effectofexchangerateoncashandcashequivalents": 5503,
    "cashandcashequivalentsperiodincreasedecrease": -4227525,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 3821712,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 136675,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 7659,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 852500,
    "contractwithcustomerliability": -2686000,
    "contractwithcustomerliabilityrevenuerecognized": 2686000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles": 3912314,
    "propertyplantandequipmentusefullife": "P2Y",
    "intangibleassetsandinprocessresearchanddevelopment": 218750,
    "deferredtaxliabilities": 365364,
    "moneymarketfundsfairvalue": 1710000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2875006,
    "contingentconsiderationfundsfairvalue": 500000,
    "paymentstoclinicaltrialservices": 978000,
    "proceedsfromissuanceofprivateplacement": 1900000,
    "propertyplantandequipmentgross": 22569,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 82729,
    "depreciation": 26672,
    "employeerelatedliabilitiescurrent": 598327,
    "accruedprofessionalfeescurrent": 259606,
    "clinicaltrialscurrent": 254144,
    "consultingexpensescurrent": 8403,
    "finitelivedintangibleassetsgross": 250000,
    "finitelivedintangibleassetsaccumulatedamortization": 31250,
    "finitelivedintangibleassetsnet": 218750,
    "finitelivedintangibleassetsresearchanddevelopment": 3912314,
    "intangibleassetsnetincludinginprocessresearchanddevelopment": 4131064,
    "finitelivedintangibleassetusefullife": "P10Y",
    "intangibleassetsexpectedmilestonepayable": 5000000000,
    "amortizationofintangibleassets": 25000,
    "commonstockothersharesoutstanding": 852500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 63632,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 14.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedweightedaverageexerciseprice": 3.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 4.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P3Y4M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageremainingcontractualterms": "P4Y9M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedinperiodweightedaverageremainingcontractualterms": "P3Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 174175,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 49994,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 9274,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 4869,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 117534,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 174175,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 27.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 28.58,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 36.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 27.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y2M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y2M5D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y2M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P8Y4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 8.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 203512,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 627000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedinperiodfairvalue": 355000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingandexercisableintrinsicvalue": 32000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 288690,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 559339,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.11,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 7523695,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -522395,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 7001300,
    "deferredfederalincometaxexpensebenefit": 4182,
    "deferredstateandlocalincometaxexpensebenefit": -99578,
    "deferredfederalstateandlocaltaxexpensebenefit": -95396,
    "deferredincometaxexpensebenefit": -95396,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.1382,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0418,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.374,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0653,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.0115,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.0045,
    "effectiveincometaxratereconciliationotheradjustments": -0.0043,
    "effectiveincometaxratecontinuingoperations": -0.0136,
    "deferredtaxassetsoperatinglosscarryforwards": 15230646,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2594055,
    "deferredtaxassetsinprocessresearchanddevelopment": 6521705,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 814438,
    "deferredtaxassetsliabilitiespropertyplantandequipment": 170,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1738482,
    "deferredtaxassetsgross": 26899496,
    "deferredtaxassetsvaluationallowance": 26278147,
    "deferredtaxassetsnet": 621349,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 986713,
    "operatinglosscarryforwardsexpirationperiod": 2039,
    "operatinglosscarryforwards": 41088000,
    "taxcreditcarryforwardamount": 504000,
    "valuationallowancedeferredtaxassetchangeinamount": 2618000,
    "lesseeoperatingleaseliabilitypaymentsremainderoffiscalyear": 86390,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2464,
    "areaofland": 4516,
    "leaseexpirationperiod": "P12Y",
    "definedbenefitplancontributionsbyemployeraccrued": 36000
  },
  {
    "date": "2018-12-30",
    "symbol": "KPRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "EYEGATE PHARMACEUTICALS INC",
    "entitycentralindexkey": 1372514,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "tradingsymbol": "EYEG",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "cashandcashequivalentsatcarryingvalue": 8004237,
    "prepaidexpenseandotherassetscurrent": 455760,
    "incometaxesreceivable": 18436,
    "assetscurrent": 8478433,
    "propertyplantandequipmentnet": 43518,
    "restrictedcashandcashequivalentsnoncurrent": 45000,
    "goodwill": 1525896,
    "intangibleassetsnetexcludinggoodwill": 250000,
    "otherassetsnoncurrent": 31706,
    "assets": 14280617,
    "accountspayablecurrent": 63654,
    "accruedliabilitiescurrent": 1114728,
    "deferredrevenuecurrent": 2686000,
    "liabilitiescurrent": 3864382,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 1210000,
    "deferredtaxliabilitiesnoncurrent": 269968,
    "liabilitiesnoncurrent": 1479968,
    "liabilities": 5344350,
    "preferredstockvalue": 41,
    "commonstockvalue": 437939,
    "additionalpaidincapital": 101514154,
    "retainedearningsaccumulateddeficit": 10932600,
    "accumulatedothercomprehensiveincomelossnetoftax": 134331,
    "stockholdersequity": 8936267,
    "liabilitiesandstockholdersequity": 14280617,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 43793878,
    "commonstocksharesoutstanding": 43793878,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 9994184,
    "preferredstocksharesissued": 4092,
    "preferredstocksharesoutstanding": 4092,
    "preferredstockdesignatedshares": 10000,
    "revenues": 1652520,
    "researchanddevelopmentexpense": 8055763,
    "generalandadministrativeexpense": 4441458,
    "operatingexpenses": 12497221,
    "investmentincomeinterest": 120363,
    "interestexpense": 1040,
    "nonoperatingincomeexpense": 119323,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -10725378,
    "incometaxexpensebenefit": 86045,
    "netincomeloss": -10811423,
    "earningspersharebasicanddiluted": -0.3,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 35483745,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 6858,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": 1652520,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 8936267,
    "sharesoutstanding": 43793878,
    "cumulativeeffectofchangeinaccountingprinciple": 9477880,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 875287,
    "stockissuedduringperiodvaluenewissues": 10108762,
    "stockissuedduringperiodsharesnewissues": 14730000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -76364,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 7638750,
    "stockissuedduringtheperiodvaluewarrantsexercised": 1205825,
    "stockissuedduringtheperiodshareswarrantsexercised": 3768125,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 3,
    "stockissuedduringperiodsharesrestrictedstockawardgross": -252,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletononcontrollinginterest": 6858,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 1141238,
    "depreciationdepletionandamortization": 38483,
    "sharebasedcompensation": 875287,
    "deferredincometaxesandtaxcredits": 86045,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -379609,
    "increasedecreaseinincometaxesreceivable": -4191,
    "increasedecreaseinotheroperatingassets": -69643,
    "increasedecreaseinaccountspayable": -642435,
    "increasedecreaseincontractwithcustomerliability": 540208,
    "increasedecreaseincontractwithcustomerasset": 689928,
    "increasedecreaseinaccruedliabilities": -694192,
    "netcashprovidedbyusedinoperatingactivities": -10844512,
    "paymentstoacquirepropertyplantandequipment": 20000,
    "paymentstoacquireintangibleassets": 250000,
    "netcashprovidedbyusedininvestingactivities": -270000,
    "proceedsfromissuanceofcommonstock": 10108762,
    "proceedsfromwarrantexercises": 1205825,
    "paymentsoffinancingcosts": 9782,
    "netcashprovidedbyusedinfinancingactivities": 11304805,
    "effectofexchangerateoncashandcashequivalents": 7915,
    "cashandcashequivalentsperiodincreasedecrease": 198208,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 8049237,
    "conversionofpreferredstockintocommonstock": 80388,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 55707739,
    "deferredrevenue": -10932600,
    "operatingincomeloss": 1652520,
    "contractwithcustomerliability": 2686000,
    "contractwithcustomerliabilityrevenuerecognized": 9627600,
    "contingentconsiderationfundsfairvalue": 1210000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles": 3912314,
    "intangibleassetsandinprocessresearchanddevelopment": 243750,
    "deferredtaxliabilities": 269968,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentgross": 99575,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 56057,
    "depreciation": 32233,
    "employeerelatedliabilitiescurrent": 722178,
    "clinicaltrialscurrrent": 212540,
    "accruedprofessionalfeescurrent": 165894,
    "consultingexpensescurrent": 9401,
    "capitalleaseobligationscurrent": 4715,
    "finitelivedintangibleassetsgross": 250000,
    "finitelivedintangibleassetsaccumulatedamortization": 6250,
    "finitelivedintangibleassetsnet": 243750,
    "finitelivedintangibleassetsresearchanddevelopment": 3912314,
    "intangibleassetsnetincludinginprocessresearchanddevelopment": 4156064,
    "finitelivedintangibleassetusefullife": "P10Y",
    "intangibleassetsexpectedmilestonepayable": 4750000,
    "amortizationofintangibleassets": 6250,
    "commonstockothersharesoutstanding": 12787500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1822132,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1890000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 108393,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 62475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedweightedaverageexerciseprice": 0.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercisedweightedaverageexerciseprice": 0.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y0M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageremainingcontractualterms": "P4Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiodweightedaverageremainingcontractualterms": "P4Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2076153,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 415500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 92158,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 140192,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1493386,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2076153,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 1.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": "P9Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y6M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y6M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P8Y0M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 0.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 875287,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1236000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 117090,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "In general, options granted under the 2014 Plan vest with respect to one-third of the underlying shares on the one-year anniversary of the grant date and the remainder ratably over a 24-month period.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 170567,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 212000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Incentive stock options may be granted to any officer or employee at an exercise price per share of not less than the fair value per common share on the date of the grant (not less than 110% of fair value in the case of holders of more than 10% of the Company&#8217;s voting stock) and with a term not to exceed ten years from the date of the grant (five years for incentive stock options granted to holders of more than 10% of the Company&#8217;s voting stock).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodfairvalue": 1049000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 11242646,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -517268,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 10725378,
    "deferredfederalincometaxexpensebenefit": -1814,
    "deferredstateandlocalincometaxexpensebenefit": -84231,
    "deferredfederalstateandlocaltaxexpensebenefit": -86045,
    "deferredincometaxexpensebenefit": -86045,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.0038,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0148,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.0388,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0106,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.0133,
    "effectiveincometaxratereconciliationattopic606adoptionpercentage": -0.209,
    "effectiveincometaxratereconciliationotheradjustments": -0.0265,
    "effectiveincometaxratecontinuingoperations": -0.008,
    "deferredtaxassetsoperatinglosscarryforwards": 13601705,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2124949,
    "deferredtaxassetsinprocessresearchanddevelopment": 5861675,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 639729,
    "deferredtaxassetsliabilitiespropertyplantandequipment": -3217,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2069985,
    "deferredtaxassetsgross": 24294826,
    "deferredtaxassetsvaluationallowance": 23659844,
    "deferredtaxassetsnet": 634982,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 904950,
    "operatinglosscarryforwardsexpirationperiod": 2038,
    "operatinglosscarryforwards": 638000,
    "taxcreditcarryforwardamount": 25000,
    "valuationallowancedeferredtaxassetchangeinamount": 416000,
    "areaofland": 4516
  },
  {
    "date": "2017-12-30",
    "symbol": "KPRX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2017-12-31",
    "documentfiscalyearfocus": 2017,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "EYEGATE PHARMACEUTICALS INC",
    "entitycentralindexkey": 1372514,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Smaller Reporting Company",
    "tradingsymbol": "EYEG",
    "cashandcashequivalentsatcarryingvalue": 7806029,
    "prepaidexpenseandotherassetscurrent": 629591,
    "incometaxesreceivable": 23685,
    "assetscurrent": 8459305,
    "propertyplantandequipmentnet": 55751,
    "restrictedcashandcashequivalentsnoncurrent": 45000,
    "goodwillandinprocessresearchanddevelopment": 5438210,
    "otherassetsnoncurrent": 307126,
    "assets": 14305392,
    "accountspayablecurrent": 706089,
    "accruedliabilitiescurrent": 1813847,
    "deferredrevenuecurrent": 12313600,
    "liabilitiescurrent": 14833536,
    "businesscombinationcontingentconsiderationliabilitynoncurrent": 1210000,
    "deferredtaxliabilities": 183923,
    "capitalleaseobligationsnoncurrent": 4855,
    "liabilitiesnoncurrent": 1398778,
    "liabilities": 16232314,
    "preferredstockvalue": 6,
    "commonstockvalue": 172573,
    "additionalpaidincapital": 89589681,
    "retainedearningsaccumulateddeficit": -91816655,
    "accumulatedothercomprehensiveincomelossnetoftax": 127473,
    "stockholdersequity": -1926922,
    "liabilitiesandstockholdersequity": 14305392,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 17257255,
    "commonstocksharesoutstanding": 17257255,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 9995828,
    "preferredstocksharesissued": 600,
    "preferredstocksharesoutstanding": 600,
    "preferredstockdesignatedshares": 10000,
    "stockissuedduringperiodsharesnewissues": 5978817,
    "proceedsfromissuanceofcommonstock": 11922252,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 400000,
    "salesrevenuenet": 407518,
    "researchanddevelopmentexpense": 10330349,
    "generalandadministrativeexpense": 4636408,
    "operatingexpenses": 14966757,
    "investmentincomeinterest": 564,
    "interestexpense": 1215,
    "nonoperatingincomeexpense": -651,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -14559890,
    "incometaxexpensebenefit": -1341973,
    "profitloss": -13217917,
    "netincomelossattributabletononcontrollinginterest": -0.93,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 14260103,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 7286,
    "comprehensiveincomenetoftaxincludingportionattributabletononcontrollinginterest": -13210631,
    "propertyplantandequipmentusefullife": "P5Y",
    "moneymarketfundsfairvalue": 750965,
    "revenuefromgrants": 3234000,
    "contingentconsiderationfundsfairvalue": 1210000,
    "goodwill": 1525896,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedintangibles": 3912314,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.34,
    "propertyplantandequipmentgross": 22569,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 23824,
    "depreciation": 19288,
    "clinicaltrialscurrrent": 807322,
    "employeerelatedliabilitiescurrent": 788551,
    "accruedprofessionalfeescurrent": 149273,
    "consultingexpensescurrent": 57487,
    "capitalleaseobligationscurrent": 11214,
    "convertiblepreferredstocktermsofconversion": "a result of such conversion, the holder, together with its affiliates, would own more than 4.99% of the shares of the Companys shares of Common Stock then issued and outstanding, which may be increased to 9.99% in certain circumstances.",
    "conversionofstocksharesconverted1": 1395,
    "commonstockothersharesoutstanding": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 9455961,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 6666667,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 63442,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 3.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedweightedaverageexerciseprice": 1.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedweightedaverageexerciseprice": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageremainingcontractualterms": "P4Y5M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiodweightedaverageremainingcontractualterms": "P7Y1M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1893003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 568450,
    "stockissuedduringperiodsharesstockoptionsexercised": 61078,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 92630,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 31450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1208450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1208450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.49,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.67,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 2.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": "P9Y4M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y10M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P4Y10M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P7Y3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcompensationcost1": 870308,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 975000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y11D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingandexercisableintrinsicvalue": 191000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 568450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "vest 33.33% on the one-year anniversary of the grant date, and the remainder ratably over the 24-month period",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 117090,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 78000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 640000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 158000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Incentive stock options may be granted to any officer or employee at an exercise price per share of not less than the fair value per common share on the date of the grant (not less than 110% of fair value in the case of holders of more than 10% of the Companys voting stock) and with a term not to exceed ten years from the date of the grant (five years for incentive stock options granted to holders of more than 10% of the Companys voting stock).",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -15102521,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 542631,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -14559890,
    "deferredfederalincometaxexpensebenefit": -1160312,
    "deferredstateandlocalincometaxexpensebenefit": -181661,
    "deferredfederalstateandlocaltaxexpensebenefit": -1341973,
    "deferredincometaxexpensebenefit": -1341973,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0468,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0267,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.4688,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0197,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.0001,
    "effectiveincometaxratereconciliationatfederalratechangepercentage": -0.7174,
    "effectiveincometaxratereconciliationotheradjustments": -0.0391,
    "effectiveincometaxratecontinuingoperations": 0.0922,
    "deferredtaxassetsoperatinglosscarryforwards": 12624253,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2002640,
    "deferredtaxassetsinprocessresearchanddevelopment": 5172541,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 552096,
    "deferredtaxassetsliabilitiespropertyplantandequipment": -82,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4459785,
    "deferredtaxassetsgross": 24811233,
    "deferredtaxassetsvaluationallowance": 24075539,
    "deferredtaxassetsnet": 735694,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 919617,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -91816655,
    "sharesoutstanding": 17257255,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 870308,
    "stockholderdebtreceivablewaiver": 58824,
    "stockissuedduringperiodvaluenewissues": 8551895,
    "preferredstockbissuedduringperiodvalue": 1977480,
    "preferredstockbissuedduringperiodshares": 1995,
    "stockissuedduringperiodvalueconversionofseriesbconvertiblesecurities": -14,
    "stockissuedduringperiodsharesconversionofseriesbconvertiblesecurities": -1395,
    "stockissuedduringperiodvaluestockoptionsexercised": 40107,
    "stockissuedduringperiodvaluerestrictedstockawardgross": -1030,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 103000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 53562,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletononcontrollinginterest": 7286,
    "operatinglosscarryforwardsexpirationperiod": 2037,
    "operatinglosscarryforwards": 3201000,
    "taxcreditcarryforwardamount": 25000,
    "valuationallowancedeferredtaxassetchangeinamount": 6800000,
    "areaofland": 4516,
    "leaseexpirationperiod": "P2Y",
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 246333,
    "depreciationdepletionandamortization": 19288,
    "sharebasedcompensation": 870308,
    "writeoffofstockholdersnotesreceivable": -91054,
    "deferredincometaxesandtaxcredits": -1341973,
    "increasedecreaseinotherreceivables": -37349,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 447570,
    "increasedecreaseinincometaxesreceivable": 4907,
    "increasedecreaseinotheroperatingassets": 1082,
    "increasedecreaseinaccountspayable": -706039,
    "increasedecreaseindeferredrevenue": 8088600,
    "increasedecreaseinaccruedliabilities": 144348,
    "netcashprovidedbyusedinoperatingactivities": -6468541,
    "paymentstoacquirepropertyplantandequipment": 36999,
    "netcashprovidedbyusedininvestingactivities": -36999,
    "proceedsfromstockoptionsexercised": 40718,
    "proceedsfromrepaymentofloansbyemployeestockownershipplans": 54097,
    "paymentsofstockissuancecosts": 1333069,
    "paymentsoffinancingcosts": 12645,
    "netcashprovidedbyusedinfinancingactivities": 10671353,
    "effectofexchangerateoncashandcashequivalents": 4992,
    "cashandcashequivalentsperiodincreasedecrease": 4170805,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7851029,
    "conversionofpreferredstockintocommonstock": 9300
  }
]